Clinical Trials Browser

Breast Neoplasms

Lung Neoplasms

Lung Diseases, Interstitial

Hodgkin Disease

Hodgkin Disease, Recurrence

Carcinoma, Non-Small-Cell Lung

Hodgkin Disease

Breast Neoplasms

Locally Advanced Non-Small Cell Lung Cancer

Hodgkin Disease, Recurrence

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms

Rhabdomyosarcoma, Sarcoma

Breast Neoplasms

Breast Neoplasms, Neoplasms

Breast Neoplasms

Rhabdomyosarcoma

Fludzoparib" and Anti-angiogenic

Colonic Neoplasms

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Breast Neoplasms

Rhabdomyosarcoma

HER2-negative Metastatic Breast Cancer

Breast Neoplasms

Multiple Myeloma

Breast Neoplasms

Breast Neoplasms

HER2-negative Breast Cancer

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Her2-negative Metastatic Breast Cancer

Breast Neoplasms, Patient Acceptance of Health Care

Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Sarcoma, Ewing

Breast Neoplasms

Rhabdomyosarcoma

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Lymphoma, T-Cell, Peripheral

Clinical Trials

ORCHID

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

IMMUNOLIFE2

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

ARCADIAN

FIL_A-BEGEV

LUNG-05

ESMART

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

AZALEA

COMET

BRIDGE

Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer

TrasTUCAN

Evolutionary Therapy for Rhabdomyosarcoma

PRECIOUS

ATREZZO

ALPHABET

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer

EORTC1616

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer

Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma

Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

PemVin vs Vin in Previously Treated Metastatic Breast Cancer

MOCCCA

Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.

SAFIR02_Breast

ORIENTA

SPRING

Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

EASOVCWDITHABC

PADMA

Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer

Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study

Detect V / CHEVENDO (Chemo vs. Endo)

FaR-RMS

Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis

Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

SMMART Adaptive Clinical Treatment (ACT) Trial

Chi-GVM Regimen for the Treatment of R/R PTCL